Appeals Court Upholds Block of Drug Pricing Transparency

A DC Circuit court upheld a federal judge’s ruling striking down the Department of Health and Human Services’ new rule requiring drug companies to disclose the price of a 30 day supply in advertising. Merck, Eli Lilly and Amgen argued that disclosing drug prices in advertisements violates their first amendment rights by controlling and compelling […]